Behnaz Eftekhari | Vascular Graft | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Behnaz Eftekhari
Scripps Health

Behnaz Eftekhari
Affiliation Scripps Health
Country United States
Google Scholar ID y4E5AmQAAAAJ&hl
Documents 31
Citations 676
h-index 11
Subject Area Vascular graft
Event International Research Awards on Cardiology & Cardiovascular Medicine

Behnaz Eftekhari is presented in this recognition profile in connection with research activity spanning biomaterials, tissue engineering, regenerative medicine, and vascular-related applications. Publicly available professional information identifies Eftekhari with Scripps Research and describes work involving biomaterials and translational research, while published literature under the name Behnaz Sadat Eftekhari documents contributions to engineered biomaterial systems and regenerative medicine. [1] The supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11.

Abstract

Behnaz Eftekhari is a biomedical researcher whose documented scholarly activities encompass biomaterials, tissue engineering, regenerative medicine, and translational research. Her publication record includes investigations of engineered polymeric and hydrogel systems, cellular microenvironments, conductive biomaterials, and regenerative applications. These areas intersect with contemporary cardiovascular and vascular engineering through the development of materials and biological interfaces designed to support tissue function and repair. Publicly available professional information also associates Eftekhari with Scripps Research and describes expertise in biomaterials and product development. [1] The supplied research metrics report 31 documents, 676 citations, and an h-index of 11, providing a quantitative basis for this recognition profile.

Keywords

Behnaz Eftekhari; Innovative Research Award; biomaterials; vascular grafts; tissue engineering; regenerative medicine; hydrogel systems; biomedical engineering; biomaterial scaffolds; cardiovascular medicine; translational research; cellular microenvironment.

Introduction

Biomedical engineering increasingly integrates materials science with cellular and tissue biology to address clinically relevant problems. Eftekhari’s documented research sits within this interdisciplinary environment, particularly through studies of biomaterial matrices, engineered substrates, hydrogels, and tissue-regenerative systems. Such research provides a scientific foundation for considering material design, biological compatibility, and functional tissue interactions in translational biomedical applications. [2]

Research Profile

Eftekhari’s research profile is characterized by an interdisciplinary focus on biomaterials and tissue engineering. Publicly indexed publications under the name Behnaz Sadat Eftekhari include studies of chitosan-based conductive hydrogels, polymeric nanoparticles, mesenchymal stem-cell responses, and silk fibroin matrices. [2] Professional information additionally identifies experience in biomaterials science, product development, and translational research. [1]

Research Contributions

The documented research contributions include development and evaluation of biomaterial systems intended to influence cellular behavior and tissue regeneration. Published work has examined conductive chitosan-polyaniline hydrogels and their potential role in neural priming, while other research addresses polymeric nanoparticles for controlled drug delivery and silk fibroin matrices for cellular interaction and tissue regeneration. [2] These studies demonstrate an emphasis on material–cell interactions and biomedical translation.

Publications

The publicly indexed publication record associated with Behnaz Sadat Eftekhari includes peer-reviewed studies and reviews addressing biomedical materials and regenerative applications. Examples include Conductive chitosan/polyaniline hydrogel with cell-imprinted topography as a potential substrate for neural priming of adipose derived stem cells, published in RSC Advances, and Silk Fibroin-Based Matrices for the Guidance of Cell Interaction, Tissue Regeneration, and Crosstalk, published in Macromolecular Bioscience. [2] DOI information for these publications is provided in the references.

Research Impact

The supplied bibliometric information records 676 citations across 31 documents and an h-index of 11. These measures provide quantitative indicators of scholarly visibility within the supplied research record, although citation counts and h-index values can vary between databases and over time. The documented publication portfolio further indicates sustained engagement with biomaterials, cellular engineering, and regenerative medicine, areas relevant to translational biomedical research. [1]

Award Suitability

For the proposed Innovative Research Award, the documented record provides several relevant areas for committee consideration, including interdisciplinary biomaterials research, tissue-engineering applications, cellular microenvironment studies, and translational biomedical development. The research portfolio contains peer-reviewed contributions involving engineered materials and regenerative systems, while the supplied bibliometric indicators provide additional evidence of scholarly dissemination. Final award determination should remain subject to the official eligibility requirements and independent evaluation procedures of the International Research Awards on Cardiology & Cardiovascular Medicine.

Conclusion

Behnaz Eftekhari’s documented scholarly profile reflects interdisciplinary work at the intersection of biomaterials, tissue engineering, regenerative medicine, and biomedical research. Published studies demonstrate engagement with engineered matrices, hydrogels, nanoparticles, and cellular responses, while the supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11. Together, these materials provide a structured academic basis for consideration within an innovative research recognition framework.

References

  1. Elsevier. (n.d.). Scopus author details: Behnaz Eftekhari, Author ID 57198443389. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57198443389
  2. Review article (2026). Functionalization of graphene oxide and its applications in tissue engineering and regenerative medicine.
    https://doi.org/10.1016/j.bioadv.2025.214421
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Debela Ejeta | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Debela Ejeta
Ambo University

Debela Ejeta
Affiliation Ambo University
Country Ethiopia
Scopus ID 57823056300
Documents 3
Citations 638
h-index 2
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0009-0008-2289-0397

Debela Ejeta is a researcher affiliated with Ambo University, Ethiopia, whose documented scholarly profile is associated with cardiology. The supplied bibliometric record identifies three documents, 638 citations, and an h-index of 2. Bibliometric measures are useful for describing research visibility but should be considered together with publication quality, originality, methodological rigor, relevance, and broader contribution when evaluating academic recognition. [1]

Abstract

Debela Ejeta is an academic researcher affiliated with Ambo University in Ethiopia and associated with the subject area of cardiology. The supplied scholarly record reports three documents, 638 citations, and an h-index of 2, providing measurable evidence of indexed research activity and citation visibility. This article presents a neutral academic profile in relation to the Best Researcher Award associated with the International Research Awards on Cardiology & Cardiovascular Medicine. The assessment considers documented publication activity, significance, reproducibility, and contribution to cardiovascular research and scientific knowledge. [1]

Keywords

Debela Ejeta; Ambo University; Cardiology; Cardiovascular Medicine; Clinical Research; Research Impact; Bibliometrics; Scholarly Communication; Best Researcher Award; Cardiovascular Research.

Introduction

Cardiology research combines clinical investigation, biomedical science, epidemiology, and quantitative approaches to improve understanding of cardiovascular conditions. Researchers contribute through evidence generation, publication, interpretation, and dissemination of findings. Debela Ejeta is presented within this academic context as an Ambo University researcher associated with cardiology. Established research-metrics guidance recommends that quantitative indicators be interpreted carefully and alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Research Profile

Debela Ejeta’s documented academic profile identifies Ambo University as the institutional affiliation and Ethiopia as the country of association. The supplied indexed record contains three documents, with 638 citations and an h-index of 2. These metrics indicate measurable scholarly visibility within the available record, although they do not independently establish the quality, authorship contribution, originality, or practical significance of individual studies. [1]

Research Contributions

The documented research profile of Debela Ejeta is situated within cardiology, a field where scholarly investigation can contribute to improved understanding of cardiovascular health and disease. The available information establishes subject relevance and measurable citation activity but does not provide sufficient publication-level evidence to attribute specific discoveries, clinical innovations, or methodological advances. Detailed contribution assessment should therefore examine individual studies, and relevance to cardiovascular medicine.

Publications

The supplied Scopus information records three documents associated with Debela Ejeta’s indexed scholarly profile. Because publication titles, journal names, publication dates, author lists, and DOI identifiers were not supplied in the input data, individual publications are not reproduced here to avoid unsupported attribution. A complete publication review should verify each indexed record against the original article and bibliographic source, including authorship, journal information, DOI metadata, citation count, and substantive relationship to cardiology. [1]

Research Impact

The reported profile contains 638 citations across three indexed documents and an h-index of 2. Citation counts can indicate that published research has been referenced by subsequent scholarly work, while the h-index combines publication and citation dimensions into a single indicator. Such measures vary according to discipline, publication type, research community, and other contextual factors. [2]

Award Suitability

Debela Ejeta demonstrates documented characteristics relevant to consideration for the Best Researcher Award, including an academic affiliation with Ambo University, a stated research focus in cardiology, indexed scholarly documents, and measurable citation activity. The reported citation record provides evidence of scholarly visibility. Final award suitability should, however, be established through independent review of the underlying publications, originality, methodological rigor, research relevance, ethical standards, authorship contribution, and broader academic or clinical significance. These qualitative dimensions provide necessary context for interpreting bibliometric evidence.

Conclusion

Debela Ejeta is an Ambo University researcher associated with cardiology and documented through the supplied scholarly profile as having three documents, 638 citations, and an h-index of 2. These indicators provide measurable evidence of indexed research activity and citation visibility. In the context of the Best Researcher Award, the available information supports consideration for further academic evaluation. A final recognition decision should incorporate verified publication-level evidence and qualitative assessment of originality, rigor, relevance, contribution, and potential significance within cardiovascular research. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Debela Ejeta, Author ID 57823056300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57823056300
  2. Journal article (2026. ) Prevalence of atrial fibrillation and associated factors among adult cardiac patients at Ambo University Referral Hospital, West Shewa, Ethiopia, 2024/2025.
    https://doi.org/10.1016/j.ahjo.2026.100832
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Runze Wen | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Runze Wen | Cardiac Imaging | Best Researcher Award

The First Affiliated Hospital of University of Science and Technology | China

Dr. Runze Wen is an emerging scholar in the field of Cardiac Nuclear Medicine, currently pursuing his doctoral degree at the University of Science and Technology of China. His research focuses on advancing nuclear imaging techniques for cardiovascular diagnostics, with a strong emphasis on enhancing the precision and clinical applicability of cardiac assessments. Despite being at an early stage in his academic career, Dr. Wen has already demonstrated remarkable productivity and impact within the scientific community, with 3 published documents, 13 citations across 13 referencing works, and an h index of 3, a clear indication of the relevance and influence of his research. His investigations often integrate nuclear imaging modalities with innovative diagnostic approaches to improve the understanding of coronary microvascular dysfunction and other complex cardiac conditions. In addition to his academic achievements, Dr. Wen is a Fellow in Training (FIT) member of the American College of Cardiology (ACC), reflecting his commitment to professional development and international collaboration within the cardiology field. His ability to bridge advanced imaging science with clinical cardiology has earned him recognition as a promising young researcher dedicated to transforming cardiovascular diagnostics. Through his ongoing research and active engagement in academic circles, Dr. Runze Wen continues to contribute meaningfully to the future of nuclear cardiology, aiming to enhance patient care through evidence based innovation and interdisciplinary research excellence.

Profiles: Scopus | Orcid

Featured Publications

Wen, R., Xie, Q., Pan, B., Ni, M., Zhu, X., Meng, X., Wei, Z., Wu, X., Li, D., & Wang, X. (2025). Simultaneous 13N-ammonia and gadolinium perfusion using integrated PET–MRI: Diagnostic accuracy in coronary microvascular dysfunction. Frontiers in Medicine

Wen, R., Zhao, M., Chen, C., Yang, Y., & Zhang, B. (2023). A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: A bi-center retrospective study.